chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Hyperhidrosis, Loss of consciousness, Pallor, Syncope, Tachycardia
Clinical narrative: After the vaccine was administered intradermally, the  patient had a syncopal episode where there was a brief loss of conciousness,  diaphoresis, tachycardia, and palor. The patient regained conciousness after about 10 seconds. Vital signs wer taken and improved over time. Please see the vitals listed below.   At 12:35pm: HR:103bpm SpO2: 98 BP: 100/60 At 12:40pm: HR: 87bpm SpO2:91 BP: 100/60 At: 12:45pm: HR: 96 bpm SpO2: 97 BP: 100/70   The patient drank 20oz of water, and was observed for 30 minutes, and felt well enough to leave the clinic.
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Migraine, Nausea, Peripheral coldness, Photophobia
Clinical narrative: Developed a migraine headache on September 13 in the early morning. Pain localized on left side of head. Nausea, light sensitivity, cold extremities experienced. Symptoms lasted for 48 hours. My last migraine was more than 15 years ago and none ever lasted more than one day.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Tinnitus
Clinical narrative: Persistent Loud buzzing  sound, ongoing after 19 hours.
Age: 72.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: Member received 2 doses due to 2 vaccines being in package.
Age: 34.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urticaria
Clinical narrative: Hives breakout all over body.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Aerococcus urinae infection, Anaemia, Angiogram pulmonary normal, Asthenia, Asymptomatic COVID-19
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 9/2/2022 Discharge Date: Sep 5, 2022  PRESENTING PROBLEM: Generalized weakness [R53.1]   HOSPITAL COURSE: 81 y.o. male with past medical history significant for dementia, coronary artery disease s/p CABG, ischemic cardiomyopathy, type 2 diabetes, hypertension, depression,BPH who presented to the emergency department with complaints of generalized weakness.  Patient does have a history of dementia and was A&O x 1-2 on admission.  Patient lives in assisted living with his wife at House.  Patient had exposure to COVID positive worker and tested positive for COVID 19 on 09/01.  Patient had noted to have slightly more confusion and was getting up at night which is abnormal for him.  This led to mechanical falls.  Upon arrival to the emergency department, patient was initially brought in as a STEMI.  EKG performed by EMS reportedly had ST elevations in V1 through V3.  EKG was obtained emergency department which did show some minimal elevation in V1 and V2 but this was noted in several prior EKGs and presentation was not consistent with STEMI/ACS.  Baseline blood work was obtained and independently reviewed.  Blood work was remarkable for BNP 4145, stable chronic anemia, troponin 40 with repeat of 42, D-dimer 1130. With reports of falls, imaging was obtained.  CT head and CT cervical spine were negative for acute process.  With elevated D-dimer, CT thorax was obtained.  CTA negative for acute PE.  With elevated D-dimer, CT thorax was obtained.  CT was negative for acute PE.  Showed dependent atelectasis in both lungs and trace left pleural effusion.  Superior endplate compression deformity at T12 was visualized without significant changes from prior imaging.  There was a somewhat irregular appearance of the vertebral body with areas of lucency of unknown significance in the T12 vertebral body.  Patient was given a dose of aspirin and home dose of metoprolol.  Patient admitted for further care.   Patient remained asymptomatic from COVID-19 standpoint on room air during the entire hospitalization.  Mentation in setting of chronic dementia remained at baseline.  Remdesivir 3 day course completed.  Patient denies urinary symptoms (however dementia).  Urine culture returned aerococcus and one dose fosfomycin given.  Noting patient clinically stable discussed with family and care management and ultimately decision was made to return patient to his current assisted living situation with his wife.  He will be monitored and if family feels he is starting to need increased level of care arrangements will be made in the outpatient setting.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Atelectasis, Blood test, Brain natriuretic peptide increased, Computerised tomogram head normal, Computerised tomogram spine
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 9/2/2022 Discharge Date: Sep 5, 2022  PRESENTING PROBLEM: Generalized weakness [R53.1]   HOSPITAL COURSE: 81 y.o. male with past medical history significant for dementia, coronary artery disease s/p CABG, ischemic cardiomyopathy, type 2 diabetes, hypertension, depression,BPH who presented to the emergency department with complaints of generalized weakness.  Patient does have a history of dementia and was A&O x 1-2 on admission.  Patient lives in assisted living with his wife at House.  Patient had exposure to COVID positive worker and tested positive for COVID 19 on 09/01.  Patient had noted to have slightly more confusion and was getting up at night which is abnormal for him.  This led to mechanical falls.  Upon arrival to the emergency department, patient was initially brought in as a STEMI.  EKG performed by EMS reportedly had ST elevations in V1 through V3.  EKG was obtained emergency department which did show some minimal elevation in V1 and V2 but this was noted in several prior EKGs and presentation was not consistent with STEMI/ACS.  Baseline blood work was obtained and independently reviewed.  Blood work was remarkable for BNP 4145, stable chronic anemia, troponin 40 with repeat of 42, D-dimer 1130. With reports of falls, imaging was obtained.  CT head and CT cervical spine were negative for acute process.  With elevated D-dimer, CT thorax was obtained.  CTA negative for acute PE.  With elevated D-dimer, CT thorax was obtained.  CT was negative for acute PE.  Showed dependent atelectasis in both lungs and trace left pleural effusion.  Superior endplate compression deformity at T12 was visualized without significant changes from prior imaging.  There was a somewhat irregular appearance of the vertebral body with areas of lucency of unknown significance in the T12 vertebral body.  Patient was given a dose of aspirin and home dose of metoprolol.  Patient admitted for further care.   Patient remained asymptomatic from COVID-19 standpoint on room air during the entire hospitalization.  Mentation in setting of chronic dementia remained at baseline.  Remdesivir 3 day course completed.  Patient denies urinary symptoms (however dementia).  Urine culture returned aerococcus and one dose fosfomycin given.  Noting patient clinically stable discussed with family and care management and ultimately decision was made to return patient to his current assisted living situation with his wife.  He will be monitored and if family feels he is starting to need increased level of care arrangements will be made in the outpatient setting.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Confusional state, Culture urine positive, Electrocardiogram ST segment elevation, Exposure to SARS-CoV-2
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 9/2/2022 Discharge Date: Sep 5, 2022  PRESENTING PROBLEM: Generalized weakness [R53.1]   HOSPITAL COURSE: 81 y.o. male with past medical history significant for dementia, coronary artery disease s/p CABG, ischemic cardiomyopathy, type 2 diabetes, hypertension, depression,BPH who presented to the emergency department with complaints of generalized weakness.  Patient does have a history of dementia and was A&O x 1-2 on admission.  Patient lives in assisted living with his wife at House.  Patient had exposure to COVID positive worker and tested positive for COVID 19 on 09/01.  Patient had noted to have slightly more confusion and was getting up at night which is abnormal for him.  This led to mechanical falls.  Upon arrival to the emergency department, patient was initially brought in as a STEMI.  EKG performed by EMS reportedly had ST elevations in V1 through V3.  EKG was obtained emergency department which did show some minimal elevation in V1 and V2 but this was noted in several prior EKGs and presentation was not consistent with STEMI/ACS.  Baseline blood work was obtained and independently reviewed.  Blood work was remarkable for BNP 4145, stable chronic anemia, troponin 40 with repeat of 42, D-dimer 1130. With reports of falls, imaging was obtained.  CT head and CT cervical spine were negative for acute process.  With elevated D-dimer, CT thorax was obtained.  CTA negative for acute PE.  With elevated D-dimer, CT thorax was obtained.  CT was negative for acute PE.  Showed dependent atelectasis in both lungs and trace left pleural effusion.  Superior endplate compression deformity at T12 was visualized without significant changes from prior imaging.  There was a somewhat irregular appearance of the vertebral body with areas of lucency of unknown significance in the T12 vertebral body.  Patient was given a dose of aspirin and home dose of metoprolol.  Patient admitted for further care.   Patient remained asymptomatic from COVID-19 standpoint on room air during the entire hospitalization.  Mentation in setting of chronic dementia remained at baseline.  Remdesivir 3 day course completed.  Patient denies urinary symptoms (however dementia).  Urine culture returned aerococcus and one dose fosfomycin given.  Noting patient clinically stable discussed with family and care management and ultimately decision was made to return patient to his current assisted living situation with his wife.  He will be monitored and if family feels he is starting to need increased level of care arrangements will be made in the outpatient setting.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Fibrin D dimer increased, Imaging procedure, Intervertebral disc disorder, Pleural effusion
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 9/2/2022 Discharge Date: Sep 5, 2022  PRESENTING PROBLEM: Generalized weakness [R53.1]   HOSPITAL COURSE: 81 y.o. male with past medical history significant for dementia, coronary artery disease s/p CABG, ischemic cardiomyopathy, type 2 diabetes, hypertension, depression,BPH who presented to the emergency department with complaints of generalized weakness.  Patient does have a history of dementia and was A&O x 1-2 on admission.  Patient lives in assisted living with his wife at House.  Patient had exposure to COVID positive worker and tested positive for COVID 19 on 09/01.  Patient had noted to have slightly more confusion and was getting up at night which is abnormal for him.  This led to mechanical falls.  Upon arrival to the emergency department, patient was initially brought in as a STEMI.  EKG performed by EMS reportedly had ST elevations in V1 through V3.  EKG was obtained emergency department which did show some minimal elevation in V1 and V2 but this was noted in several prior EKGs and presentation was not consistent with STEMI/ACS.  Baseline blood work was obtained and independently reviewed.  Blood work was remarkable for BNP 4145, stable chronic anemia, troponin 40 with repeat of 42, D-dimer 1130. With reports of falls, imaging was obtained.  CT head and CT cervical spine were negative for acute process.  With elevated D-dimer, CT thorax was obtained.  CTA negative for acute PE.  With elevated D-dimer, CT thorax was obtained.  CT was negative for acute PE.  Showed dependent atelectasis in both lungs and trace left pleural effusion.  Superior endplate compression deformity at T12 was visualized without significant changes from prior imaging.  There was a somewhat irregular appearance of the vertebral body with areas of lucency of unknown significance in the T12 vertebral body.  Patient was given a dose of aspirin and home dose of metoprolol.  Patient admitted for further care.   Patient remained asymptomatic from COVID-19 standpoint on room air during the entire hospitalization.  Mentation in setting of chronic dementia remained at baseline.  Remdesivir 3 day course completed.  Patient denies urinary symptoms (however dementia).  Urine culture returned aerococcus and one dose fosfomycin given.  Noting patient clinically stable discussed with family and care management and ultimately decision was made to return patient to his current assisted living situation with his wife.  He will be monitored and if family feels he is starting to need increased level of care arrangements will be made in the outpatient setting.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Sleep disorder, Spinal cord compression, Troponin
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 9/2/2022 Discharge Date: Sep 5, 2022  PRESENTING PROBLEM: Generalized weakness [R53.1]   HOSPITAL COURSE: 81 y.o. male with past medical history significant for dementia, coronary artery disease s/p CABG, ischemic cardiomyopathy, type 2 diabetes, hypertension, depression,BPH who presented to the emergency department with complaints of generalized weakness.  Patient does have a history of dementia and was A&O x 1-2 on admission.  Patient lives in assisted living with his wife at House.  Patient had exposure to COVID positive worker and tested positive for COVID 19 on 09/01.  Patient had noted to have slightly more confusion and was getting up at night which is abnormal for him.  This led to mechanical falls.  Upon arrival to the emergency department, patient was initially brought in as a STEMI.  EKG performed by EMS reportedly had ST elevations in V1 through V3.  EKG was obtained emergency department which did show some minimal elevation in V1 and V2 but this was noted in several prior EKGs and presentation was not consistent with STEMI/ACS.  Baseline blood work was obtained and independently reviewed.  Blood work was remarkable for BNP 4145, stable chronic anemia, troponin 40 with repeat of 42, D-dimer 1130. With reports of falls, imaging was obtained.  CT head and CT cervical spine were negative for acute process.  With elevated D-dimer, CT thorax was obtained.  CTA negative for acute PE.  With elevated D-dimer, CT thorax was obtained.  CT was negative for acute PE.  Showed dependent atelectasis in both lungs and trace left pleural effusion.  Superior endplate compression deformity at T12 was visualized without significant changes from prior imaging.  There was a somewhat irregular appearance of the vertebral body with areas of lucency of unknown significance in the T12 vertebral body.  Patient was given a dose of aspirin and home dose of metoprolol.  Patient admitted for further care.   Patient remained asymptomatic from COVID-19 standpoint on room air during the entire hospitalization.  Mentation in setting of chronic dementia remained at baseline.  Remdesivir 3 day course completed.  Patient denies urinary symptoms (however dementia).  Urine culture returned aerococcus and one dose fosfomycin given.  Noting patient clinically stable discussed with family and care management and ultimately decision was made to return patient to his current assisted living situation with his wife.  He will be monitored and if family feels he is starting to need increased level of care arrangements will be made in the outpatient setting.
Age: 44.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Extra dose administered, Wrong technique in product usage process
Clinical narrative: No Wheal and observed leakage on first Intradermal administration attempt. Successful 2nd administration intradermally
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Insomnia, Mobility decreased, Pain in extremity, Vomiting
Clinical narrative: Within 3 hours, unable to lift arm., unable to sleep. Severe arm pain for three days, then started vomiiting and vomited for 2 days.
Age: 26.0
Sex: F
Vaccine: FLUC4
Symptoms: Pruritus
Clinical narrative: Systemic: Allergic: Itch Generalized-Medium
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient received booster dose (0.25 ml) of monovalent on September 9th 2022, which was after August 31st, 2022.  Follow up call was made to the patient and no adverse event was reported.  Patient was informed that she can get the new bivalent booster dose after two months from the last time she received the monovalent booster.
Age: 62.0
Sex: U
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: No adverse events were experienced 5 patients were vaccinated with Monovalent Pfizer Vaccine as a booster between 9/3 thru 9/13, after the approval of the Bivalent vaccine, when the monovalent vaccine was no longer authorized to be used as a booster.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Bacteraemia, Blood glucose, COVID-19 pneumonia, Central venous catheterisation
Clinical narrative: Discharge Provider : MD Primary Care Provider:  MD Admission Date: 9/4/2022 Discharge Date: Sep 13, 2022  PRESENTING PROBLEM: Severe sepsis Diabetic ketoacidosis without coma associated with type 2 diabetes mellitus Community acquired pneumonia of right lower lobe of lung COVID-19 Bacteremia   HOSPITAL COURSE: 34 year old female w/PMH including T2DM, severe persistent asthma with no baseline oxygen needs, OSA, obesity, presenting with worsening dyspnea, fatigue, general malaise, and right-sided chest wall pain. Initial workup revealed acute hypoxemic respiratory failure secondary to COVID-19 pneumonia, superimposed bacterial PNA, and DKA. She was started on IV insulin, given steroids in the ED, and admitted to the ICU for further management.  While in the ICU, her oxygen requirements improved but she was found to have MRSA bacteremia. Vancomycin was started and ID were consulted.    Once the patient was taken off of EndoTool and switched to basal bolus insulin she was transferred to the medical floor.  Sputum culture was positive for MRSA and therefore she was being treated for pneumonia secondary to MRSA.  Infectious Disease gave final recommendation with continuous vancomycin infusion for a total of 4 weeks.  Home oxygen eval showed that the patient needs 2 liters of nasal cannula continuous which was arranged for her.  PICC line was placed prior to discharge.   Of note few days prior to discharge, the patient glucose level was dropping the for her and Lantus was decreased as well as her pre meal insulin.  Endocrinology was following and adjusted her bolus insulin and provided recommendations on discharge.    The patient was discharged home in a stable condition with home health care and discharge instructions provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Diabetic ketoacidosis, Dyspnoea, Fatigue, Intensive care, Malaise
Clinical narrative: Discharge Provider : MD Primary Care Provider:  MD Admission Date: 9/4/2022 Discharge Date: Sep 13, 2022  PRESENTING PROBLEM: Severe sepsis Diabetic ketoacidosis without coma associated with type 2 diabetes mellitus Community acquired pneumonia of right lower lobe of lung COVID-19 Bacteremia   HOSPITAL COURSE: 34 year old female w/PMH including T2DM, severe persistent asthma with no baseline oxygen needs, OSA, obesity, presenting with worsening dyspnea, fatigue, general malaise, and right-sided chest wall pain. Initial workup revealed acute hypoxemic respiratory failure secondary to COVID-19 pneumonia, superimposed bacterial PNA, and DKA. She was started on IV insulin, given steroids in the ED, and admitted to the ICU for further management.  While in the ICU, her oxygen requirements improved but she was found to have MRSA bacteremia. Vancomycin was started and ID were consulted.    Once the patient was taken off of EndoTool and switched to basal bolus insulin she was transferred to the medical floor.  Sputum culture was positive for MRSA and therefore she was being treated for pneumonia secondary to MRSA.  Infectious Disease gave final recommendation with continuous vancomycin infusion for a total of 4 weeks.  Home oxygen eval showed that the patient needs 2 liters of nasal cannula continuous which was arranged for her.  PICC line was placed prior to discharge.   Of note few days prior to discharge, the patient glucose level was dropping the for her and Lantus was decreased as well as her pre meal insulin.  Endocrinology was following and adjusted her bolus insulin and provided recommendations on discharge.    The patient was discharged home in a stable condition with home health care and discharge instructions provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal chest pain, Pneumonia, Pneumonia bacterial, Sepsis, Sputum culture positive
Clinical narrative: Discharge Provider : MD Primary Care Provider:  MD Admission Date: 9/4/2022 Discharge Date: Sep 13, 2022  PRESENTING PROBLEM: Severe sepsis Diabetic ketoacidosis without coma associated with type 2 diabetes mellitus Community acquired pneumonia of right lower lobe of lung COVID-19 Bacteremia   HOSPITAL COURSE: 34 year old female w/PMH including T2DM, severe persistent asthma with no baseline oxygen needs, OSA, obesity, presenting with worsening dyspnea, fatigue, general malaise, and right-sided chest wall pain. Initial workup revealed acute hypoxemic respiratory failure secondary to COVID-19 pneumonia, superimposed bacterial PNA, and DKA. She was started on IV insulin, given steroids in the ED, and admitted to the ICU for further management.  While in the ICU, her oxygen requirements improved but she was found to have MRSA bacteremia. Vancomycin was started and ID were consulted.    Once the patient was taken off of EndoTool and switched to basal bolus insulin she was transferred to the medical floor.  Sputum culture was positive for MRSA and therefore she was being treated for pneumonia secondary to MRSA.  Infectious Disease gave final recommendation with continuous vancomycin infusion for a total of 4 weeks.  Home oxygen eval showed that the patient needs 2 liters of nasal cannula continuous which was arranged for her.  PICC line was placed prior to discharge.   Of note few days prior to discharge, the patient glucose level was dropping the for her and Lantus was decreased as well as her pre meal insulin.  Endocrinology was following and adjusted her bolus insulin and provided recommendations on discharge.    The patient was discharged home in a stable condition with home health care and discharge instructions provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Staphylococcal bacteraemia, Staphylococcus test positive, Superinfection
Clinical narrative: Discharge Provider : MD Primary Care Provider:  MD Admission Date: 9/4/2022 Discharge Date: Sep 13, 2022  PRESENTING PROBLEM: Severe sepsis Diabetic ketoacidosis without coma associated with type 2 diabetes mellitus Community acquired pneumonia of right lower lobe of lung COVID-19 Bacteremia   HOSPITAL COURSE: 34 year old female w/PMH including T2DM, severe persistent asthma with no baseline oxygen needs, OSA, obesity, presenting with worsening dyspnea, fatigue, general malaise, and right-sided chest wall pain. Initial workup revealed acute hypoxemic respiratory failure secondary to COVID-19 pneumonia, superimposed bacterial PNA, and DKA. She was started on IV insulin, given steroids in the ED, and admitted to the ICU for further management.  While in the ICU, her oxygen requirements improved but she was found to have MRSA bacteremia. Vancomycin was started and ID were consulted.    Once the patient was taken off of EndoTool and switched to basal bolus insulin she was transferred to the medical floor.  Sputum culture was positive for MRSA and therefore she was being treated for pneumonia secondary to MRSA.  Infectious Disease gave final recommendation with continuous vancomycin infusion for a total of 4 weeks.  Home oxygen eval showed that the patient needs 2 liters of nasal cannula continuous which was arranged for her.  PICC line was placed prior to discharge.   Of note few days prior to discharge, the patient glucose level was dropping the for her and Lantus was decreased as well as her pre meal insulin.  Endocrinology was following and adjusted her bolus insulin and provided recommendations on discharge.    The patient was discharged home in a stable condition with home health care and discharge instructions provided.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: Many patients were coming in for their 12, and 16-year-old shots all day, but especially the afternoon.  The patient that the error occurred with came in for a second dose of pediatric Pfizer.  I had not given this vaccine in quite a while and just pulled up the shot like I had been doing with the 12 and 16-year-old shots and forgot to dilute the medicine and drew up 0.2 ml of the undiluted vaccine.  The patient?s mother was there when I gave the vaccine.  After giving the vaccine I told the mother to wait for 15 minutes in the lobby with the child.  A few minutes later my supervisor came in to the vaccine room and noticed that the Pfizer vial was not as full as it should be.  I then realized that I did not dilute the vaccine.  We checked on the patient.  She had no symptoms or irritation at the site, and she stated that she felt fine.  Then we consulted the vaccine coordinator on what to do next.  She discussed with the supervisor what to explain to the Mother.  The supervisor explained to the mother to keep an eye on the patient and that the area of the shot might be red and irritated and to call us with any questions, and to seek emergency help should anything severe occur.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: patient hospitalized with COVID
Age: 34.0
Sex: M
Vaccine: SMALLMNK
Symptoms: No adverse event, Vaccination error
Clinical narrative: The first intradermal attempt did not result in a wheel. No physical adverse event occured. A second attmept was administered by an expert, and was successful.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Tested COVID positive, symptoms include sore throat, cough, and shortness of breath.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue
Clinical narrative: fatigue,  chest tightness
Age: 21.0
Sex: F
Vaccine: FLU4
Symptoms: Pruritus, Rash
Clinical narrative: rash to body, itching
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy
Clinical narrative: Bells Palsy
Age: 1.0
Sex: F
Vaccine: MMRV, VARCEL
Symptoms: Irritability, Wrong product administered
Clinical narrative: Patient received doses of Varicella vaccine component as CMA administered MMR-Varicella (Proquad) instead of ordered MMR. (Vaccines ordered at time of visit: PCV13, Varicella, MMR, HepA, and Hib) Mother reported mild fussiness after vaccines, otherwise asymptomatic and at baseline 48 hours after vaccination
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: We received yesterday from the Health Department  a Moderna vial labelled in the paper work as Booster & the vial mentioned Booster Only. We thought this was the Bivalent vaccine we ordered. We had a patient coming today requesting the Booster. We administered 0.5 ml of the Booster vial. Patient tolerated the vaccine with no complications. However when we started documenting the vaccine we realized that the Booster labelled Moderna vaccine had the same Lot # as the Pediatric Moderna 6-11 years. Then we went to the guidelines & realized that the Moderna Bivalent should have a Gray border & the wording Bivalent on it.  We contacted Moderna representative & she mentioned currently Moderna does not repeat the dose in such cases of accidental administration of  Primary series vaccine for a Booster dose.
Age: 32.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Arthralgia, Back pain, Blood test abnormal, Chest pain, Echocardiogram normal
Clinical narrative: He got his 2nd vaccine, he had been getting back pain the next day out of nowhere.  He was putting pain patches on it thinking it was muscle pain.  On Thursday he left work early as he was having a lot of back pain.  As he was driving home he noticed that he was not feeling well.  He was home alone so he went to medical center and had a low heart beat and low BP.  He was taken to the hospital and diagnosed with pericarditis.  They did all kind of tests, and was given some anti-inflammatories 800 mg, Colchicine to help treat the pericarditis.  But it's a viral condition so the pain comes and goes.  He was discharged after 10 days,.  He went back to the hospital this monday due to the pain, and his PCP did blood work with high SED rate and came back to the hospital and has been in the hospital since Monday, 9/12/22.  He has had a lot of tests done, is still in the hospital.  He is having pain in his chest, shoulder, neck area.    He had an echocardiogram, which was OK, but does not know when he is going to go home.  He was in medical center 8/25/22 to 9/4/22.    He is now in Hospital since 9/12/22 and does not know when he will be discharged.
Age: 32.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Heart rate decreased, Hypotension, Impaired work ability, Laboratory test, Malaise
Clinical narrative: He got his 2nd vaccine, he had been getting back pain the next day out of nowhere.  He was putting pain patches on it thinking it was muscle pain.  On Thursday he left work early as he was having a lot of back pain.  As he was driving home he noticed that he was not feeling well.  He was home alone so he went to medical center and had a low heart beat and low BP.  He was taken to the hospital and diagnosed with pericarditis.  They did all kind of tests, and was given some anti-inflammatories 800 mg, Colchicine to help treat the pericarditis.  But it's a viral condition so the pain comes and goes.  He was discharged after 10 days,.  He went back to the hospital this monday due to the pain, and his PCP did blood work with high SED rate and came back to the hospital and has been in the hospital since Monday, 9/12/22.  He has had a lot of tests done, is still in the hospital.  He is having pain in his chest, shoulder, neck area.    He had an echocardiogram, which was OK, but does not know when he is going to go home.  He was in medical center 8/25/22 to 9/4/22.    He is now in Hospital since 9/12/22 and does not know when he will be discharged.
Age: 32.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Neck pain, Pericarditis, Red blood cell sedimentation rate increased, Viral pericarditis
Clinical narrative: He got his 2nd vaccine, he had been getting back pain the next day out of nowhere.  He was putting pain patches on it thinking it was muscle pain.  On Thursday he left work early as he was having a lot of back pain.  As he was driving home he noticed that he was not feeling well.  He was home alone so he went to medical center and had a low heart beat and low BP.  He was taken to the hospital and diagnosed with pericarditis.  They did all kind of tests, and was given some anti-inflammatories 800 mg, Colchicine to help treat the pericarditis.  But it's a viral condition so the pain comes and goes.  He was discharged after 10 days,.  He went back to the hospital this monday due to the pain, and his PCP did blood work with high SED rate and came back to the hospital and has been in the hospital since Monday, 9/12/22.  He has had a lot of tests done, is still in the hospital.  He is having pain in his chest, shoulder, neck area.    He had an echocardiogram, which was OK, but does not know when he is going to go home.  He was in medical center 8/25/22 to 9/4/22.    He is now in Hospital since 9/12/22 and does not know when he will be discharged.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: After the 4 dose I did not have any symptoms until September 1st, 2022, that I went a trip. I flew I wear my mask at the terminal and on the plane. I got there on the 2nd of September, and then I attended a funeral on September 3rd, then I probably exposed; no one wear mask including myself and that's when I probably got COVID-19. When I returned home, I tested myself on Thursday September 8th and it was Positive. I felt congestive, coughing, a little tired. The symptoms got worst while I was traveling that night. The next day after I took the test, I called my doctor, and he gave me Paxlovid, and I took it for 5 days. I don't think it helped a lot.
Age: 21.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood urea nitrogen/creatinine ratio decreased, Burning sensation, Coagulopathy, Contusion, Decreased appetite
Clinical narrative: After the 1st injection April 13, 2022 and the second injection on May 4, 2022, the patient experienced severe burning sensation of the head, dizziness for one month, still has nausea, vaginal bleeding, poor appetite, hives and swelling both feet and ankles, difficulty with blood draws the needle and tubes clot off, multiple bruises of BUE and BLE easily and severe fatigue.
Age: 21.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Fatigue, Increased tendency to bruise, Joint swelling, Metabolic function test
Clinical narrative: After the 1st injection April 13, 2022 and the second injection on May 4, 2022, the patient experienced severe burning sensation of the head, dizziness for one month, still has nausea, vaginal bleeding, poor appetite, hives and swelling both feet and ankles, difficulty with blood draws the needle and tubes clot off, multiple bruises of BUE and BLE easily and severe fatigue.
Age: 21.0
Sex: F
Vaccine: COVID19-2
Symptoms: Nausea, Peripheral swelling, Protein deficiency, Urticaria, Vaginal haemorrhage
Clinical narrative: After the 1st injection April 13, 2022 and the second injection on May 4, 2022, the patient experienced severe burning sensation of the head, dizziness for one month, still has nausea, vaginal bleeding, poor appetite, hives and swelling both feet and ankles, difficulty with blood draws the needle and tubes clot off, multiple bruises of BUE and BLE easily and severe fatigue.
Age: 21.0
Sex: F
Vaccine: COVID19-2
Symptoms: Weight gain poor
Clinical narrative: After the 1st injection April 13, 2022 and the second injection on May 4, 2022, the patient experienced severe burning sensation of the head, dizziness for one month, still has nausea, vaginal bleeding, poor appetite, hives and swelling both feet and ankles, difficulty with blood draws the needle and tubes clot off, multiple bruises of BUE and BLE easily and severe fatigue.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Dyspnoea, Nausea, Vomiting
Clinical narrative: SOB, diarrhea, nausea, vomiting, dizziness, light-headedness
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was given Pfizer monovalent vaccine booster instead of Pfizer bivalent booster.  Patient was contacted and was ok with receiving the bivalent vaccine in 2 months.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Body temperature increased, Headache, Nausea, Pain
Clinical narrative: Headache, nausea, nasty body aches, temp over 102 lasting over 48 hours.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Nurse understood that patient needed the bivalent Pfizer, instead of the start of the Pfizer series.  No adverse event reported so far.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Death, Myalgia, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID 5/17/2022, died 5/27/2022. Symptoms included muscle aches and cough.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient tested positive for covid and hospitalized although he received the vaccine
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Vision blurred
Clinical narrative: hazy vision in right eye which may have begun before patient woke up. effect was moderate, as if viewing everything through a piece of plastic film or a dirty glass window. symptoms persisted until around 11:00AM that day and then subsided and have not returned.
Age: 33.0
Sex: F
Vaccine: UNK
Symptoms: Exposure during pregnancy
Clinical narrative: Patient was given HPV vaccine and stated afterwards that she was pregnant. No harm to date reported by patients
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood follicle stimulating hormone increased, Hormone level abnormal, Menstruation irregular, Night sweats, Oestradiol decreased
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA. I developed night sweats with each vaccine. I also skipped my menses for three months after the covid vaccines.
Age: 36.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Extra dose administered, Injection site discharge
Clinical narrative: Vaccine given ID in R forearm. Leakage occurred. Vaccine re-administered 2 inches from 1st. No leakage. Dose administered successfully.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased
Clinical narrative: 105 degree F temperature in the middle of the night and then, 103 degree temperature for the next several days (4)
Age: 20.0
Sex: F
Vaccine: COVID19-2
Symptoms: Balance disorder, Chills, Disturbance in attention, Dizziness, Feeling abnormal
Clinical narrative: Moderate dizzyness, starting 04:00 am 09/14 and ending 10:00 am 09/14. Balance issues (see below), vision feeling "one inch in front of eyes", brain fog (see below), difficulty judging distances. Moderate balance issues, starting 04:00 am 09/14 and ending 02:00 pm 09/14. Swaying, increased need to sit. Moderate brain fog, starting 06:00 am 09/14, decreasing to light symptoms at 01:00 pm, ending at 08:30 pm 09/14. Difficulty concentrating and remembering fine details. Moderate full body chills and aches, starting 08:00 pm 09/13, ending 04:00 pm 09/14.
Age: 20.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Photophobia, Visual impairment
Clinical narrative: Moderate dizzyness, starting 04:00 am 09/14 and ending 10:00 am 09/14. Balance issues (see below), vision feeling "one inch in front of eyes", brain fog (see below), difficulty judging distances. Moderate balance issues, starting 04:00 am 09/14 and ending 02:00 pm 09/14. Swaying, increased need to sit. Moderate brain fog, starting 06:00 am 09/14, decreasing to light symptoms at 01:00 pm, ending at 08:30 pm 09/14. Difficulty concentrating and remembering fine details. Moderate full body chills and aches, starting 08:00 pm 09/13, ending 04:00 pm 09/14.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was given Moderna monovalent booster instead of Moderna bivalent booster.  Patient was contacted and informed and was ok with receiving their bivalent booster in 2 months.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, Cough, Dysphagia, Fatigue
Clinical narrative: I started getting a sore throat. I was at a major conference when I began having problems swallowing and my throat hurt. It just hit me like a brick. I was going to spend another night, but I decided to head home that day. I started feeling extremely run down and had a cough. I pulled off the highway at around 09:00PM to a rest stop. I happened to have some COVID-19 tests with me so I took two and they were both positive. I called my workplace to inform them of my positive results so that they could tell others who had been with me. I then continued driving home and returned home at around 11PM. I had a fever, chest pain, cough. I felt like I had the flu. I called my doctor in the morning. I am on Stelara which lowers your immune system, so my doctor arraigned for me to receive a monoclonal antibody infusion on 06/18/2022. They told me it would take around 48 hours for me to feel the effects. It took less than 24 hours for me to feel significantly better. For the next 2 days, I felt exhausted but better. I continued to feel fatigued and slept a lot for the following 5-6 weeks. I could work, but not a whole day. I would fall asleep in the middle of the day for about a month.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersomnia, Impaired work ability, Influenza like illness, Oropharyngeal pain, Pyrexia
Clinical narrative: I started getting a sore throat. I was at a major conference when I began having problems swallowing and my throat hurt. It just hit me like a brick. I was going to spend another night, but I decided to head home that day. I started feeling extremely run down and had a cough. I pulled off the highway at around 09:00PM to a rest stop. I happened to have some COVID-19 tests with me so I took two and they were both positive. I called my workplace to inform them of my positive results so that they could tell others who had been with me. I then continued driving home and returned home at around 11PM. I had a fever, chest pain, cough. I felt like I had the flu. I called my doctor in the morning. I am on Stelara which lowers your immune system, so my doctor arraigned for me to receive a monoclonal antibody infusion on 06/18/2022. They told me it would take around 48 hours for me to feel the effects. It took less than 24 hours for me to feel significantly better. For the next 2 days, I felt exhausted but better. I continued to feel fatigued and slept a lot for the following 5-6 weeks. I could work, but not a whole day. I would fall asleep in the middle of the day for about a month.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sudden onset of sleep
Clinical narrative: I started getting a sore throat. I was at a major conference when I began having problems swallowing and my throat hurt. It just hit me like a brick. I was going to spend another night, but I decided to head home that day. I started feeling extremely run down and had a cough. I pulled off the highway at around 09:00PM to a rest stop. I happened to have some COVID-19 tests with me so I took two and they were both positive. I called my workplace to inform them of my positive results so that they could tell others who had been with me. I then continued driving home and returned home at around 11PM. I had a fever, chest pain, cough. I felt like I had the flu. I called my doctor in the morning. I am on Stelara which lowers your immune system, so my doctor arraigned for me to receive a monoclonal antibody infusion on 06/18/2022. They told me it would take around 48 hours for me to feel the effects. It took less than 24 hours for me to feel significantly better. For the next 2 days, I felt exhausted but better. I continued to feel fatigued and slept a lot for the following 5-6 weeks. I could work, but not a whole day. I would fall asleep in the middle of the day for about a month.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against, then tested positive for COVID-19.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Exercise tolerance decreased, Impaired work ability, Magnetic resonance imaging abnormal, Menstrual disorder, Pain in extremity
Clinical narrative: I am a registered nurse.  This is my account.  One month after my Moderna dose, I experienced abnormal menstrual cycles.   Two months after my second Moderna dose, I started to experience foot pain in the morning.  I was later diagnosed with plantar fascitis.  I saw a DOM and began treatment in June 2021, including hydrocortisone shots, stretching and getting custom orthotics.  I was unable to resume normal exercise (running, Peloton) that I had prior to being vaccinated.  I was unable to pick up extra shifts due to foot pain.   The injections helped initially, along with stretches.  But later the pain returned and I had to pursue surgery.  I saw that Plantar Fasciitis was listed as rare SE.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Plantar fasciitis, Surgery
Clinical narrative: I am a registered nurse.  This is my account.  One month after my Moderna dose, I experienced abnormal menstrual cycles.   Two months after my second Moderna dose, I started to experience foot pain in the morning.  I was later diagnosed with plantar fascitis.  I saw a DOM and began treatment in June 2021, including hydrocortisone shots, stretching and getting custom orthotics.  I was unable to resume normal exercise (running, Peloton) that I had prior to being vaccinated.  I was unable to pick up extra shifts due to foot pain.   The injections helped initially, along with stretches.  But later the pain returned and I had to pursue surgery.  I saw that Plantar Fasciitis was listed as rare SE.
Age: 64.0
Sex: F
Vaccine: PNC20
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient came in stating they wanted a pneumonia vaccine.  patient was given the vaccine, pharmacist later realized patient was under 65 and for health conditions had hypertension and high cholesterol which does not fall within the chronic conditions to vaccinate under 65
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Fatigue, Mobility decreased
Clinical narrative: I experienced fatigue and a cough originally. The cough was consistent throughout for about a month. I am still trying to recover from the fatigue. I was sneezing and had congestion but the cough was the worst symptom. I tested myself for COVID-19 on July 19, 2022. I went to the emergency room on the first day. After waiting for 5 hours I left and was not treated. My general practitioner was out of the country at the time that I had the breakthrough case. I received some advice from the doctor that was covering for her afterwards and I spoke to 2 separate doctors over the phone that prescribed the medication for me. I was treated with albuterol, a cough syrup and benzonatate 100 mg capsules. The albuterol was not helpful but the cough syrup was. I did have a chest x-ray which was clear. I tested negative on August 05th, 2022. I have recovered from COVID 19 after 3 weeks. I am still recovering from fatigue and mobility issues. I am in physical therapy in an attempt to get back to where I was.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Sneezing, Vaccine breakthrough infection
Clinical narrative: I experienced fatigue and a cough originally. The cough was consistent throughout for about a month. I am still trying to recover from the fatigue. I was sneezing and had congestion but the cough was the worst symptom. I tested myself for COVID-19 on July 19, 2022. I went to the emergency room on the first day. After waiting for 5 hours I left and was not treated. My general practitioner was out of the country at the time that I had the breakthrough case. I received some advice from the doctor that was covering for her afterwards and I spoke to 2 separate doctors over the phone that prescribed the medication for me. I was treated with albuterol, a cough syrup and benzonatate 100 mg capsules. The albuterol was not helpful but the cough syrup was. I did have a chest x-ray which was clear. I tested negative on August 05th, 2022. I have recovered from COVID 19 after 3 weeks. I am still recovering from fatigue and mobility issues. I am in physical therapy in an attempt to get back to where I was.
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: FEVER UP TO 102.0 X 6 DAYS.
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Confusional state, Incontinence, Peripheral swelling, Pyrexia
Clinical narrative: Patient stated her arm began to sell and feel feverish in the early morning late evening after the vaccine.  She said she was "out of her head", didn't know where she was and incontinent
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was given Pfizer monovalent booster instead of Pfizer bivalent booster.  Patient was contacted and informed and was ok with receiving their bivalent booster in 2 months.
Age: 61.0
Sex: M
Vaccine: PNC20
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient came in requested the pneumonia vaccine , pharmacist later realized pt did not have any chronic health conditions for patient to get the vaccine under the age of 65